114 related articles for article (PubMed ID: 18774708)
1. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Venkatesh M; Banerjee S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5233-7. PubMed ID: 18774708
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia.
Mallia MB; Subramanian S; Banerjee S; Sarma HD; Venkatesh M
Bioorg Med Chem; 2006 Dec; 14(23):7666-70. PubMed ID: 16949291
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
4. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
5. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
Mallia MB; Mittal S; Sarma HD; Banerjee S
Bioorg Med Chem Lett; 2016 Jan; 26(1):46-50. PubMed ID: 26615889
[TBL] [Abstract][Full Text] [Related]
6. On the structural modification of 2-nitroimidazole-(99m)Tc(CO)(3) complex, a hypoxia marker, for improving in vivo pharmacokinetics.
Mallia MB; Kumar C; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2012 Nov; 39(8):1236-42. PubMed ID: 22938843
[TBL] [Abstract][Full Text] [Related]
7. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of [
Ruan Q; Zhang X; Gan Q; Fang S; Zhang J
Bioorg Med Chem Lett; 2020 Nov; 30(22):127582. PubMed ID: 33002601
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a novel (99m)Tc labeled 2-nitroimidazole derivative as a potential agent for imaging tumor hypoxia.
Joyard Y; Le Joncour V; Castel H; Diouf CB; Bischoff L; Papamicaël C; Levacher V; Vera P; Bohn P
Bioorg Med Chem Lett; 2013 Jul; 23(13):3704-8. PubMed ID: 23726027
[TBL] [Abstract][Full Text] [Related]
10. In vivo click reaction between Tc-99m-labeled azadibenzocyclooctyne-MAMA and 2-nitroimidazole-azide for tumor hypoxia targeting.
Sun W; Chu T
Bioorg Med Chem Lett; 2015 Oct; 25(20):4453-6. PubMed ID: 26358160
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole (99m)Tc-complexes as potential agents for targeting hypoxia.
Giglio J; Fernández S; Rey A; Cerecetto H
Bioorg Med Chem Lett; 2011 Jan; 21(1):394-7. PubMed ID: 21087863
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
13. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.
Zhang Q; Zhang Q; Guan Y; Liu S; Chen Q; Li X
Med Sci Monit; 2016 Oct; 22():3778-3791. PubMed ID: 27752036
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
Giglio J; Fernández S; Pietzsch HJ; Dematteis S; Moreno M; Pacheco JP; Cerecetto H; Rey A
Nucl Med Biol; 2012 Jul; 39(5):679-86. PubMed ID: 22534030
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
17. A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells.
Su ZF; Ballinger JR; Rauth AM; Abrams DN; Billinghurst MW
Bioconjug Chem; 2000; 11(5):652-63. PubMed ID: 10995208
[TBL] [Abstract][Full Text] [Related]
18. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.
Su ZF; Zhang X; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 1999; 10(5):897-904. PubMed ID: 10502359
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.
Chu T; Hu S; Wei B; Wang Y; Liu X; Wang X
Bioorg Med Chem Lett; 2004 Feb; 14(3):747-9. PubMed ID: 14741282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
